Cargando…
Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway
Ulcerative colitis (UC) is a refractory chronic disease characterized by bloody diarrhea and mucosal or submucosal ulcers. There is an urgent need of new drugs for the treatment of ulcerative colitis. EHLJ7 is a quaternary coptisine derivative. Herein, we explored the therapeutic effect of EHLJ7 on...
Autores principales: | Tang, Xiaonan, Li, Xiang, Wang, Yufei, Zhang, ZhiHui, Deng, AnJun, Wang, WenJie, Zhang, Haijing, Qin, Hailin, Wu, LianQiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987075/ https://www.ncbi.nlm.nih.gov/pubmed/32038241 http://dx.doi.org/10.3389/fphar.2019.01553 |
Ejemplares similares
-
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition
por: Song, Huachen, et al.
Publicado: (2020) -
Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway
por: Zhang, HaiJing, et al.
Publicado: (2017) -
Three new lignan glucosides from the roots of Scutellaria baicalensis
por: Long, Hailin, et al.
Publicado: (2016) -
Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis
por: Zhao, Hai-Mei, et al.
Publicado: (2016) -
The molecular basis of JAK/STAT inhibition by SOCS1
por: Liau, Nicholas P. D., et al.
Publicado: (2018)